[1]
|
S. Yan and G. Wu. (2009) Describing evolution of hemagglutinins from influenza A viruses using a differential equation, Protein Pept. Lett., 16, 794–804.
|
[2]
|
G. Wu and S. Yan. (2002) Randomness in the primary structure of protein: Methods and implications, Mol. Biol. Today, 3, 55–69.
|
[3]
|
G. Wu and S. Yan. (2006) Mutation trend of hemagglutinin of influenza A virus: A review from computational mutation viewpoint, Acta Pharmacol. Sin., 27, 513–526.
|
[4]
|
G. Wu and S. Yan. (2006) Fate of influenza A virus proteins, Protein Pept. Lett., 13, 377–384.
|
[5]
|
G. Wu and S. Yan. (2008) Lecture notes on computational mutation, Nova Science Publishers, New York.
|
[6]
|
T. Betakova. (2007) M2 protein-a proton channel of influenza A virus, Curr. Pharm. Des., 13, 3231–3235.
|
[7]
|
L. H. Pinto and R. A. Lamb. (2007) Controlling influenza virus replication by inhibiting its proton channel, Mol. Biosyst., 3, 18–23
|
[8]
|
J. Beigel and M. Bray. (2008) Current and future antiviral therapy of severe seasonal and avian influenza, Antiviral Res., 78, 91–102.
|
[9]
|
E. De Clercq and J. Neyts. (2007) Avian influenza A (H5N1) infection: Targets and strategies for chemotherapeutic intervention, Trends Pharmacol. Sci., 28, 280–285.
|
[10]
|
F. Hayden. (2009) Developing new antiviral agents for influenza treatment: What does the future hold? Clin. Infect. Dis., 48, S3–S13.
|
[11]
|
M. Schotsaert, M. De Filette, W. Fiers and X. Saelens. (2009) Universal M2 ectodomain-based influenza A vaccines: Preclinical and clinical developments, Expert Rev. Vaccines, 8, 499–508.
|
[12]
|
Influenza virus resources, (2009)
http://www.ncbi.nlm.nih.gov/genomes/FLU/Database/multiple.cgi.
|
[13]
|
SPSS Inc., (2002) SigmaPlot for Windows, Version 8.02.
|
[14]
|
G. Wu. (1996) Fit fluctuating blood drug concentration: A beginner’s first note, Pharmacol. Res., 33, 379–383.
|
[15]
|
K. Yamaoka, T. Nakagawa and T. Uno. (1978) Application of Akaike’s information criterion (AIC) in the eva- luation of linear pharmacoketic equations, J. Pharmacokinet. Biopharm., 6, 165–175.
|
[16]
|
G. Wu, P. Cossettini and M. Furlanut. (1996) Prediction of blood cyclosporine concentrations in haematological patients with multidrug resistance by one-, two- and three-compartment models using Bayesian and nonlinear least squares methods, Pharmacol. Res., 34, 47–57.
|
[17]
|
G. Wu and S. Yan. (2006) Timing of mutation in hemagglutinins from influenza A virus by means of amino-acid distribution rank and fast Fourier transform, Protein Pept. Lett., 13, 143–148.
|
[18]
|
G. Wu and S. Yan. (2005) Timing of mutation in hemagglutinins from influenza A virus by means of unpredictable portion of amino-acid pair and fast Fourier transform, Biochem. Biophys. Res. Commun., 333, 70–78.
|
[19]
|
G. Wu and S. Yan. (2005) Searching of main cause leading to severe influenza A virus mutations and consequently to influenza pandemics/epidemics, Am. J. Infect. Dis., 1, 116–123.
|
[20]
|
S. Yan and G. Wu. (2009) Prediction of mutation position, mutated amino acid and timing in hemagglutinins from North America H1 influenza A virus, J. Biomed. Sci. Eng, 2, 190–199.
|